Products Categories
  • Mr.Yang
    Tel: +86-21-51623867

  • Mobile:+86-15618786686
  • Tel:+86-21-51623867
  • Fax:+86-21-51623867
  • URL:http://www.rechemscience.com/
  • Province/state:Shanghai
  • City:Shanghai
  • Street:Shanghai
  • MaxCard:
Home > Products >  Tafluprost(AFP-168)/ supplier with competitive price in stock-Rechems

Tafluprost(AFP-168)/ supplier with competitive price in stock-Rechems CAS NO.209860-87-7

  • Min.Order: 0
  • Payment Terms:
  • Product Details

Keywords

  • Tafluprost
  • AFP-168
  • 209860-87-7 manufacturer

Quick Details

  • ProName: Tafluprost(AFP-168)/ supplier with com...
  • CasNo: 209860-87-7
  • Molecular Formula: C??H??F?O?
  • Application: Medicinal Chemistry 、 Biomedicine、 Pha...
  • DeliveryTime: 1-2days after the payment
  • PackAge: Bottle and bag according to customer
  • Port: Shanghai, Shenzhen
  • Purity: 98%
  • Storage: Stored in well-closed containers
  • Transportation: DHL,UPS,FEDEX EMS or as your request
  • LimitNum: 0

Superiority

1.Custom synthetic service could be provided and COA/HPLC/HNMR is available.
2.Professional synthesis laboratory and production base.
3.Strong synthesis team and service team.
4.Professional data management system.
5.We provide the professional test date and product information.
6.Rich shipping methods,ex. Fedex,DHL,TNT,BY SEA and BY AIR.
7. We can accept various payment methods,Paypal,T/T, etc.
8.Professional packaging can be according the customers’requirment.

Details

Tafluprost(AFP-168) is an anti-glaucoma prostaglandin (PG) analog.Target:Others Tafluprost showed significant IOP-lowering effects without any safety concerns in patients with various types of glaucoma and OH in daily clinical practice and tafluprost is highly effective in any therapeutic patterns .Tafluprost with reduced BAK has potential as a superior antiglaucoma drug, not only for its IOP-lowering effect, but also for its good corneal safety profile .Tafluprost single-use vials treatment was effective in reducing IOP over the 3 years of this study, but visual field performance worsened by 10.3%-13.8% in patients with normal-tension glaucoma.Safety was satisfactory .
Shanghai Rechem science Co., Ltd.
Rechemsis focus on R&D of new APIS, signal transduction inhibitors and pharmaceutical intermediates. We follow closely the industry trend, and the latest research achievements in life science area.
Rechems is located in the largest biomedical base in China--Shanghai and cooperatively established modern production base and laboratory in surrounding areas. We have built up a good relationship with many US / European / Japanese pharmaceutical companies to conduct chemical research and inventory trading in medicinal chemistry.
Rechems's mission is to serve pharmaceutical community by providing excellent services and high-quality products in a timely manner.
Rechems's vision is to be recognized by our clients as one of the best suppliers of chemical products for our superior quality, efficient and cost-effective services.
We insist the principle of "Quality first, customer foremost, best credit, be pioneering and creative", looking forward to establishing good business relationships with customers all over the world. Let's work together for bright future!

Other products of this supplier

lookchemhot product CAS New CAS Cas Database Article Data Chemical Catalog